Cancer drugs spared funding axe following appeals

By Nick Renaud-Komiya2015-03-13T13:07:00

Source: Evgeny Rannev

Three drugs that NHS England said would be axed from the cancer drugs fund will remain available at least temporarily, following a series of appeals by drug companies.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here